Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (159)
Solid Biosciences Inc. (SLDB)
Brooks Gabriel — Chief Medical Officer
Shares
4,374
Price
$5.62
Total Value
$24.58K
Shares Held After
97,241
% of Holdings
4.3%
EXAGEN INC. (XGN)
Chernett Jorey — 10% Owner
Shares
14,000
Price
$7.46
Total Value
$104.44K
Shares Held After
2,618,540
% of Holdings
0.5%
Nano-X Imaging Ltd. (NNOX)
Meltzer Erez — Director
Shares
25,000
Price
$0.45
Total Value
$11.25K
Shares Held After
90,443
% of Holdings
27.6%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
6,000
Price
$0.75
Total Value
$4.49K
Shares Held After
10,577,186
% of Holdings
0.1%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
6,000
Price
$0.70
Total Value
$4.20K
Shares Held After
10,571,186
% of Holdings
0.1%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
3,600
Price
$0.70
Total Value
$2.52K
Shares Held After
10,565,186
% of Holdings
0.0%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
6,000
Price
$0.70
Total Value
$4.20K
Shares Held After
10,561,586
% of Holdings
0.1%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
6,969
Price
$0.69
Total Value
$4.81K
Shares Held After
10,555,586
% of Holdings
0.1%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
2,000
Price
$0.70
Total Value
$1.40K
Shares Held After
10,548,617
% of Holdings
0.0%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
3,000
Price
$0.70
Total Value
$2.10K
Shares Held After
10,546,617
% of Holdings
0.0%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
98
Price
$409.34
Total Value
$40.12K
Shares Held After
8,250
% of Holdings
1.2%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
80
Price
$406.06
Total Value
$32.48K
Shares Held After
8,348
% of Holdings
0.9%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
90
Price
$403.70
Total Value
$36.33K
Shares Held After
8,428
% of Holdings
1.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
60
Price
$401.62
Total Value
$24.10K
Shares Held After
8,518
% of Holdings
0.7%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
280
Price
$400.68
Total Value
$112.19K
Shares Held After
8,578
% of Holdings
3.2%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
142
Price
$398.95
Total Value
$56.65K
Shares Held After
8,858
% of Holdings
1.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
80
Price
$409.36
Total Value
$32.75K
Shares Held After
8,250
% of Holdings
1.0%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
35
Price
$406.62
Total Value
$14.23K
Shares Held After
8,330
% of Holdings
0.4%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
50
Price
$405.15
Total Value
$20.26K
Shares Held After
8,365
% of Holdings
0.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
90
Price
$404.25
Total Value
$36.38K
Shares Held After
8,415
% of Holdings
1.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
280
Price
$401.29
Total Value
$112.36K
Shares Held After
8,505
% of Holdings
3.2%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
215
Price
$399.34
Total Value
$85.86K
Shares Held After
8,785
% of Holdings
2.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
300
Price
$0.95
Total Value
$285.00
Shares Held After
385,385
% of Holdings
0.1%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
118,185
Price
$2.34
Total Value
$276.55K
Shares Held After
2,958,820
% of Holdings
4.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1
Price
$1.32
Total Value
$1.32
Shares Held After
955,494
% of Holdings
0.0%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
1,635
Price
$12.84
Total Value
$20.99K
Shares Held After
8,617
% of Holdings
15.9%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
53
Price
$43.54
Total Value
$2.31K
Shares Held After
390
% of Holdings
12.0%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
1,357
Price
$43.54
Total Value
$59.08K
Shares Held After
17,811
% of Holdings
7.1%
ENSIGN GROUP, INC (ENSG)
Parkinson Mark Vincent — Director
Shares
100
Price
$179.62
Total Value
$17.96K
Shares Held After
4,400
% of Holdings
2.2%
EXAGEN INC. (XGN)
ABALLI JOHN — Director
Shares
34,294
Price
$7.87
Total Value
$269.79K
Shares Held After
805,540
% of Holdings
4.1%
Guardant Health, Inc. (GH)
Tariq Musa — Director
Shares
116
Price
$165.88
Total Value
$19.24K
Shares Held After
11,583
% of Holdings
1.0%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
4,788
Price
$0.34
Total Value
$1.65K
Shares Held After
18,616
% of Holdings
20.5%
X4 Pharmaceuticals, Inc (XFOR)
Craig Adam R — Director
Shares
4,600
Price
$2.58
Total Value
$11.88K
Shares Held After
333,251
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$543.85
Total Value
$21.75K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
391
Price
$542.67
Total Value
$212.19K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
169
Price
$541.62
Total Value
$91.53K
Shares Held After
324,874
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
239
Price
$539.60
Total Value
$128.96K
Shares Held After
325,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$538.55
Total Value
$215.96K
Shares Held After
325,282
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$537.74
Total Value
$408.68K
Shares Held After
325,683
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
865
Price
$536.66
Total Value
$464.21K
Shares Held After
326,443
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
535
Price
$535.67
Total Value
$286.58K
Shares Held After
327,308
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$534.41
Total Value
$342.02K
Shares Held After
327,843
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,818
Price
$533.32
Total Value
$969.58K
Shares Held After
328,483
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,378
Price
$532.46
Total Value
$1.27M
Shares Held After
330,301
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,024
Price
$531.54
Total Value
$544.30K
Shares Held After
332,679
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$530.48
Total Value
$127.31K
Shares Held After
333,703
% of Holdings
0.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
36,347
Price
$1.89
Total Value
$68.76K
Shares Held After
2,944,354
% of Holdings
1.2%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
25,000
Price
$23.98
Total Value
$599.60K
Shares Held After
1,047,205
% of Holdings
2.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
300
Price
$25.45
Total Value
$7.63K
Shares Held After
377,802
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,581
Price
$24.21
Total Value
$280.38K
Shares Held After
378,102
% of Holdings
3.0%
159 transactions